nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—Vismodegib—Sorafenib—thyroid cancer	0.549	1	CrCrCtD
Etoricoxib—PTGS2—thyroid cancer	0.221	1	CbGaD
Etoricoxib—CYP2C19—Sorafenib—thyroid cancer	0.0153	0.18	CbGbCtD
Etoricoxib—CYP1A2—Sorafenib—thyroid cancer	0.0141	0.166	CbGbCtD
Etoricoxib—CYP2C9—Sorafenib—thyroid cancer	0.0127	0.15	CbGbCtD
Etoricoxib—CYP3A4—Vandetanib—thyroid cancer	0.0123	0.144	CbGbCtD
Etoricoxib—CYP2D6—Sorafenib—thyroid cancer	0.0116	0.137	CbGbCtD
Etoricoxib—CYP3A4—Sorafenib—thyroid cancer	0.00738	0.087	CbGbCtD
Etoricoxib—CYP2D6—Doxorubicin—thyroid cancer	0.00705	0.083	CbGbCtD
Etoricoxib—CYP3A4—Doxorubicin—thyroid cancer	0.00448	0.0528	CbGbCtD
Etoricoxib—Vemurafenib—BRAF—thyroid cancer	0.00327	0.887	CrCbGaD
Etoricoxib—Celecoxib—PTGS2—thyroid cancer	0.000418	0.113	CrCbGaD
Etoricoxib—Blood urea increased—Doxorubicin—thyroid cancer	0.000147	0.00147	CcSEcCtD
Etoricoxib—Vaginal infection—Doxorubicin—thyroid cancer	0.000147	0.00147	CcSEcCtD
Etoricoxib—Neuropathy—Doxorubicin—thyroid cancer	0.000146	0.00146	CcSEcCtD
Etoricoxib—Dyspnoea—Sorafenib—thyroid cancer	0.000144	0.00145	CcSEcCtD
Etoricoxib—Nausea—Vandetanib—thyroid cancer	0.000143	0.00143	CcSEcCtD
Etoricoxib—Dyspepsia—Sorafenib—thyroid cancer	0.000143	0.00143	CcSEcCtD
Etoricoxib—Decreased appetite—Sorafenib—thyroid cancer	0.000141	0.00141	CcSEcCtD
Etoricoxib—Mouth ulceration—Doxorubicin—thyroid cancer	0.00014	0.00141	CcSEcCtD
Etoricoxib—Ecchymosis—Doxorubicin—thyroid cancer	0.00014	0.00141	CcSEcCtD
Etoricoxib—Neoplasm—Doxorubicin—thyroid cancer	0.00014	0.00141	CcSEcCtD
Etoricoxib—Bladder pain—Doxorubicin—thyroid cancer	0.00014	0.00141	CcSEcCtD
Etoricoxib—Diabetes mellitus—Epirubicin—thyroid cancer	0.00014	0.0014	CcSEcCtD
Etoricoxib—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00014	0.0014	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00014	0.0014	CcSEcCtD
Etoricoxib—Fatigue—Sorafenib—thyroid cancer	0.00014	0.0014	CcSEcCtD
Etoricoxib—Pain—Sorafenib—thyroid cancer	0.000139	0.00139	CcSEcCtD
Etoricoxib—Constipation—Sorafenib—thyroid cancer	0.000139	0.00139	CcSEcCtD
Etoricoxib—Hepatic failure—Epirubicin—thyroid cancer	0.000136	0.00136	CcSEcCtD
Etoricoxib—Eczema—Epirubicin—thyroid cancer	0.000136	0.00136	CcSEcCtD
Etoricoxib—Cardiac failure congestive—Epirubicin—thyroid cancer	0.000134	0.00134	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000133	0.00133	CcSEcCtD
Etoricoxib—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00013	0.0013	CcSEcCtD
Etoricoxib—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00013	0.0013	CcSEcCtD
Etoricoxib—Urticaria—Sorafenib—thyroid cancer	0.000129	0.00129	CcSEcCtD
Etoricoxib—Abdominal pain—Sorafenib—thyroid cancer	0.000128	0.00128	CcSEcCtD
Etoricoxib—Renal impairment—Epirubicin—thyroid cancer	0.000128	0.00128	CcSEcCtD
Etoricoxib—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000126	0.00126	CcSEcCtD
Etoricoxib—Eczema—Doxorubicin—thyroid cancer	0.000125	0.00126	CcSEcCtD
Etoricoxib—Hepatic failure—Doxorubicin—thyroid cancer	0.000125	0.00126	CcSEcCtD
Etoricoxib—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000124	0.00124	CcSEcCtD
Etoricoxib—Cardiac failure congestive—Doxorubicin—thyroid cancer	0.000124	0.00124	CcSEcCtD
Etoricoxib—Pain in extremity—Epirubicin—thyroid cancer	0.000122	0.00122	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000122	0.00122	CcSEcCtD
Etoricoxib—Hypersensitivity—Sorafenib—thyroid cancer	0.000119	0.00119	CcSEcCtD
Etoricoxib—Renal impairment—Doxorubicin—thyroid cancer	0.000118	0.00119	CcSEcCtD
Etoricoxib—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000116	0.00117	CcSEcCtD
Etoricoxib—Asthenia—Sorafenib—thyroid cancer	0.000116	0.00116	CcSEcCtD
Etoricoxib—Cardiac arrest—Epirubicin—thyroid cancer	0.000116	0.00116	CcSEcCtD
Etoricoxib—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000115	0.00115	CcSEcCtD
Etoricoxib—Pruritus—Sorafenib—thyroid cancer	0.000115	0.00115	CcSEcCtD
Etoricoxib—Blood creatinine increased—Epirubicin—thyroid cancer	0.000114	0.00114	CcSEcCtD
Etoricoxib—Pain in extremity—Doxorubicin—thyroid cancer	0.000113	0.00113	CcSEcCtD
Etoricoxib—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000113	0.00113	CcSEcCtD
Etoricoxib—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000111	0.00111	CcSEcCtD
Etoricoxib—Diarrhoea—Sorafenib—thyroid cancer	0.000111	0.00111	CcSEcCtD
Etoricoxib—Breast disorder—Epirubicin—thyroid cancer	0.00011	0.0011	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00011	0.0011	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00011	0.0011	CcSEcCtD
Etoricoxib—Gastritis—Epirubicin—thyroid cancer	0.000108	0.00108	CcSEcCtD
Etoricoxib—Muscular weakness—Epirubicin—thyroid cancer	0.000107	0.00108	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000107	0.00108	CcSEcCtD
Etoricoxib—Cardiac arrest—Doxorubicin—thyroid cancer	0.000107	0.00107	CcSEcCtD
Etoricoxib—Dizziness—Sorafenib—thyroid cancer	0.000107	0.00107	CcSEcCtD
Etoricoxib—Abdominal distension—Epirubicin—thyroid cancer	0.000106	0.00106	CcSEcCtD
Etoricoxib—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000106	0.00106	CcSEcCtD
Etoricoxib—Pancreatitis—Epirubicin—thyroid cancer	0.000103	0.00103	CcSEcCtD
Etoricoxib—Vomiting—Sorafenib—thyroid cancer	0.000103	0.00103	CcSEcCtD
Etoricoxib—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000103	0.00103	CcSEcCtD
Etoricoxib—Angina pectoris—Epirubicin—thyroid cancer	0.000103	0.00103	CcSEcCtD
Etoricoxib—Rash—Sorafenib—thyroid cancer	0.000102	0.00102	CcSEcCtD
Etoricoxib—Dermatitis—Sorafenib—thyroid cancer	0.000102	0.00102	CcSEcCtD
Etoricoxib—Breast disorder—Doxorubicin—thyroid cancer	0.000102	0.00102	CcSEcCtD
Etoricoxib—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000102	0.00102	CcSEcCtD
Etoricoxib—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000102	0.00102	CcSEcCtD
Etoricoxib—Headache—Sorafenib—thyroid cancer	0.000102	0.00102	CcSEcCtD
Etoricoxib—Bronchitis—Epirubicin—thyroid cancer	0.000101	0.00101	CcSEcCtD
Etoricoxib—Gastritis—Doxorubicin—thyroid cancer	9.98e-05	0.000998	CcSEcCtD
Etoricoxib—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	9.94e-05	0.000995	CcSEcCtD
Etoricoxib—Muscular weakness—Doxorubicin—thyroid cancer	9.94e-05	0.000995	CcSEcCtD
Etoricoxib—Abdominal distension—Doxorubicin—thyroid cancer	9.81e-05	0.000982	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Epirubicin—thyroid cancer	9.79e-05	0.000979	CcSEcCtD
Etoricoxib—Nausea—Sorafenib—thyroid cancer	9.63e-05	0.000963	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Epirubicin—thyroid cancer	9.61e-05	0.000962	CcSEcCtD
Etoricoxib—Weight increased—Epirubicin—thyroid cancer	9.58e-05	0.000959	CcSEcCtD
Etoricoxib—Pancreatitis—Doxorubicin—thyroid cancer	9.55e-05	0.000956	CcSEcCtD
Etoricoxib—Hyperglycaemia—Epirubicin—thyroid cancer	9.5e-05	0.000951	CcSEcCtD
Etoricoxib—Angina pectoris—Doxorubicin—thyroid cancer	9.49e-05	0.00095	CcSEcCtD
Etoricoxib—Pneumonia—Epirubicin—thyroid cancer	9.44e-05	0.000945	CcSEcCtD
Etoricoxib—Infestation NOS—Epirubicin—thyroid cancer	9.39e-05	0.00094	CcSEcCtD
Etoricoxib—Infestation—Epirubicin—thyroid cancer	9.39e-05	0.00094	CcSEcCtD
Etoricoxib—Bronchitis—Doxorubicin—thyroid cancer	9.37e-05	0.000938	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	9.31e-05	0.000932	CcSEcCtD
Etoricoxib—Renal failure—Epirubicin—thyroid cancer	9.23e-05	0.000924	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Epirubicin—thyroid cancer	9.2e-05	0.000921	CcSEcCtD
Etoricoxib—Stomatitis—Epirubicin—thyroid cancer	9.15e-05	0.000916	CcSEcCtD
Etoricoxib—Jaundice—Epirubicin—thyroid cancer	9.15e-05	0.000916	CcSEcCtD
Etoricoxib—Urinary tract infection—Epirubicin—thyroid cancer	9.13e-05	0.000913	CcSEcCtD
Etoricoxib—Conjunctivitis—Epirubicin—thyroid cancer	9.13e-05	0.000913	CcSEcCtD
Etoricoxib—Upper respiratory tract infection—Doxorubicin—thyroid cancer	9.06e-05	0.000906	CcSEcCtD
Etoricoxib—Haematuria—Epirubicin—thyroid cancer	8.95e-05	0.000896	CcSEcCtD
Etoricoxib—Photosensitivity reaction—Doxorubicin—thyroid cancer	8.89e-05	0.00089	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Epirubicin—thyroid cancer	8.88e-05	0.000889	CcSEcCtD
Etoricoxib—Weight increased—Doxorubicin—thyroid cancer	8.87e-05	0.000887	CcSEcCtD
Etoricoxib—Epistaxis—Epirubicin—thyroid cancer	8.86e-05	0.000886	CcSEcCtD
Etoricoxib—Sinusitis—Epirubicin—thyroid cancer	8.81e-05	0.000882	CcSEcCtD
Etoricoxib—Hyperglycaemia—Doxorubicin—thyroid cancer	8.79e-05	0.00088	CcSEcCtD
Etoricoxib—Pneumonia—Doxorubicin—thyroid cancer	8.74e-05	0.000874	CcSEcCtD
Etoricoxib—Infestation NOS—Doxorubicin—thyroid cancer	8.69e-05	0.000869	CcSEcCtD
Etoricoxib—Infestation—Doxorubicin—thyroid cancer	8.69e-05	0.000869	CcSEcCtD
Etoricoxib—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	8.61e-05	0.000862	CcSEcCtD
Etoricoxib—Renal failure—Doxorubicin—thyroid cancer	8.54e-05	0.000855	CcSEcCtD
Etoricoxib—Neuropathy peripheral—Doxorubicin—thyroid cancer	8.52e-05	0.000852	CcSEcCtD
Etoricoxib—Haemoglobin—Epirubicin—thyroid cancer	8.47e-05	0.000848	CcSEcCtD
Etoricoxib—Stomatitis—Doxorubicin—thyroid cancer	8.47e-05	0.000847	CcSEcCtD
Etoricoxib—Jaundice—Doxorubicin—thyroid cancer	8.47e-05	0.000847	CcSEcCtD
Etoricoxib—Conjunctivitis—Doxorubicin—thyroid cancer	8.45e-05	0.000845	CcSEcCtD
Etoricoxib—Urinary tract infection—Doxorubicin—thyroid cancer	8.45e-05	0.000845	CcSEcCtD
Etoricoxib—Haemorrhage—Epirubicin—thyroid cancer	8.43e-05	0.000844	CcSEcCtD
Etoricoxib—Hepatitis—Epirubicin—thyroid cancer	8.43e-05	0.000844	CcSEcCtD
Etoricoxib—Hypoaesthesia—Epirubicin—thyroid cancer	8.39e-05	0.000839	CcSEcCtD
Etoricoxib—Pharyngitis—Epirubicin—thyroid cancer	8.37e-05	0.000837	CcSEcCtD
Etoricoxib—Urinary tract disorder—Epirubicin—thyroid cancer	8.32e-05	0.000833	CcSEcCtD
Etoricoxib—Oedema peripheral—Epirubicin—thyroid cancer	8.3e-05	0.000831	CcSEcCtD
Etoricoxib—Haematuria—Doxorubicin—thyroid cancer	8.28e-05	0.000829	CcSEcCtD
Etoricoxib—Connective tissue disorder—Epirubicin—thyroid cancer	8.28e-05	0.000829	CcSEcCtD
Etoricoxib—Urethral disorder—Epirubicin—thyroid cancer	8.26e-05	0.000827	CcSEcCtD
Etoricoxib—Hepatobiliary disease—Doxorubicin—thyroid cancer	8.22e-05	0.000822	CcSEcCtD
Etoricoxib—Epistaxis—Doxorubicin—thyroid cancer	8.19e-05	0.00082	CcSEcCtD
Etoricoxib—Sinusitis—Doxorubicin—thyroid cancer	8.15e-05	0.000816	CcSEcCtD
Etoricoxib—Visual impairment—Epirubicin—thyroid cancer	8.12e-05	0.000813	CcSEcCtD
Etoricoxib—Erythema multiforme—Epirubicin—thyroid cancer	7.97e-05	0.000798	CcSEcCtD
Etoricoxib—Eye disorder—Epirubicin—thyroid cancer	7.88e-05	0.000788	CcSEcCtD
Etoricoxib—Tinnitus—Epirubicin—thyroid cancer	7.86e-05	0.000786	CcSEcCtD
Etoricoxib—Haemoglobin—Doxorubicin—thyroid cancer	7.84e-05	0.000784	CcSEcCtD
Etoricoxib—Flushing—Epirubicin—thyroid cancer	7.82e-05	0.000783	CcSEcCtD
Etoricoxib—Cardiac disorder—Epirubicin—thyroid cancer	7.82e-05	0.000783	CcSEcCtD
Etoricoxib—Haemorrhage—Doxorubicin—thyroid cancer	7.8e-05	0.00078	CcSEcCtD
Etoricoxib—Hepatitis—Doxorubicin—thyroid cancer	7.8e-05	0.00078	CcSEcCtD
Etoricoxib—Hypoaesthesia—Doxorubicin—thyroid cancer	7.76e-05	0.000777	CcSEcCtD
Etoricoxib—Pharyngitis—Doxorubicin—thyroid cancer	7.74e-05	0.000775	CcSEcCtD
Etoricoxib—Urinary tract disorder—Doxorubicin—thyroid cancer	7.7e-05	0.000771	CcSEcCtD
Etoricoxib—Oedema peripheral—Doxorubicin—thyroid cancer	7.68e-05	0.000769	CcSEcCtD
Etoricoxib—Connective tissue disorder—Doxorubicin—thyroid cancer	7.66e-05	0.000767	CcSEcCtD
Etoricoxib—Angiopathy—Epirubicin—thyroid cancer	7.65e-05	0.000765	CcSEcCtD
Etoricoxib—Urethral disorder—Doxorubicin—thyroid cancer	7.65e-05	0.000765	CcSEcCtD
Etoricoxib—Immune system disorder—Epirubicin—thyroid cancer	7.61e-05	0.000762	CcSEcCtD
Etoricoxib—Mediastinal disorder—Epirubicin—thyroid cancer	7.6e-05	0.00076	CcSEcCtD
Etoricoxib—Arrhythmia—Epirubicin—thyroid cancer	7.53e-05	0.000754	CcSEcCtD
Etoricoxib—Visual impairment—Doxorubicin—thyroid cancer	7.52e-05	0.000752	CcSEcCtD
Etoricoxib—Alopecia—Epirubicin—thyroid cancer	7.45e-05	0.000745	CcSEcCtD
Etoricoxib—Mental disorder—Epirubicin—thyroid cancer	7.39e-05	0.000739	CcSEcCtD
Etoricoxib—Erythema multiforme—Doxorubicin—thyroid cancer	7.37e-05	0.000738	CcSEcCtD
Etoricoxib—Erythema—Epirubicin—thyroid cancer	7.34e-05	0.000734	CcSEcCtD
Etoricoxib—Malnutrition—Epirubicin—thyroid cancer	7.34e-05	0.000734	CcSEcCtD
Etoricoxib—Eye disorder—Doxorubicin—thyroid cancer	7.29e-05	0.000729	CcSEcCtD
Etoricoxib—Tinnitus—Doxorubicin—thyroid cancer	7.27e-05	0.000728	CcSEcCtD
Etoricoxib—Cardiac disorder—Doxorubicin—thyroid cancer	7.24e-05	0.000724	CcSEcCtD
Etoricoxib—Flushing—Doxorubicin—thyroid cancer	7.24e-05	0.000724	CcSEcCtD
Etoricoxib—Flatulence—Epirubicin—thyroid cancer	7.23e-05	0.000724	CcSEcCtD
Etoricoxib—Dysgeusia—Epirubicin—thyroid cancer	7.19e-05	0.000719	CcSEcCtD
Etoricoxib—Angiopathy—Doxorubicin—thyroid cancer	7.08e-05	0.000708	CcSEcCtD
Etoricoxib—Muscle spasms—Epirubicin—thyroid cancer	7.05e-05	0.000706	CcSEcCtD
Etoricoxib—Immune system disorder—Doxorubicin—thyroid cancer	7.04e-05	0.000705	CcSEcCtD
Etoricoxib—Mediastinal disorder—Doxorubicin—thyroid cancer	7.03e-05	0.000703	CcSEcCtD
Etoricoxib—Arrhythmia—Doxorubicin—thyroid cancer	6.97e-05	0.000697	CcSEcCtD
Etoricoxib—Vision blurred—Epirubicin—thyroid cancer	6.92e-05	0.000692	CcSEcCtD
Etoricoxib—Alopecia—Doxorubicin—thyroid cancer	6.89e-05	0.00069	CcSEcCtD
Etoricoxib—Mental disorder—Doxorubicin—thyroid cancer	6.83e-05	0.000684	CcSEcCtD
Etoricoxib—Malnutrition—Doxorubicin—thyroid cancer	6.79e-05	0.000679	CcSEcCtD
Etoricoxib—Erythema—Doxorubicin—thyroid cancer	6.79e-05	0.000679	CcSEcCtD
Etoricoxib—Anaemia—Epirubicin—thyroid cancer	6.78e-05	0.000679	CcSEcCtD
Etoricoxib—Agitation—Epirubicin—thyroid cancer	6.74e-05	0.000675	CcSEcCtD
Etoricoxib—Flatulence—Doxorubicin—thyroid cancer	6.69e-05	0.000669	CcSEcCtD
Etoricoxib—Dysgeusia—Doxorubicin—thyroid cancer	6.65e-05	0.000665	CcSEcCtD
Etoricoxib—Muscle spasms—Doxorubicin—thyroid cancer	6.53e-05	0.000653	CcSEcCtD
Etoricoxib—Palpitations—Epirubicin—thyroid cancer	6.48e-05	0.000649	CcSEcCtD
Etoricoxib—Cough—Epirubicin—thyroid cancer	6.4e-05	0.000641	CcSEcCtD
Etoricoxib—Vision blurred—Doxorubicin—thyroid cancer	6.4e-05	0.00064	CcSEcCtD
Etoricoxib—Hypertension—Epirubicin—thyroid cancer	6.34e-05	0.000634	CcSEcCtD
Etoricoxib—Anaemia—Doxorubicin—thyroid cancer	6.28e-05	0.000628	CcSEcCtD
Etoricoxib—Arthralgia—Epirubicin—thyroid cancer	6.25e-05	0.000625	CcSEcCtD
Etoricoxib—Chest pain—Epirubicin—thyroid cancer	6.25e-05	0.000625	CcSEcCtD
Etoricoxib—Agitation—Doxorubicin—thyroid cancer	6.24e-05	0.000624	CcSEcCtD
Etoricoxib—Anxiety—Epirubicin—thyroid cancer	6.23e-05	0.000623	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	6.2e-05	0.000621	CcSEcCtD
Etoricoxib—Dry mouth—Epirubicin—thyroid cancer	6.11e-05	0.000611	CcSEcCtD
Etoricoxib—Confusional state—Epirubicin—thyroid cancer	6.04e-05	0.000604	CcSEcCtD
Etoricoxib—Palpitations—Doxorubicin—thyroid cancer	6e-05	0.0006	CcSEcCtD
Etoricoxib—Oedema—Epirubicin—thyroid cancer	5.99e-05	0.000599	CcSEcCtD
Etoricoxib—Anaphylactic shock—Epirubicin—thyroid cancer	5.99e-05	0.000599	CcSEcCtD
Etoricoxib—Infection—Epirubicin—thyroid cancer	5.95e-05	0.000595	CcSEcCtD
Etoricoxib—Cough—Doxorubicin—thyroid cancer	5.92e-05	0.000593	CcSEcCtD
Etoricoxib—Shock—Epirubicin—thyroid cancer	5.89e-05	0.00059	CcSEcCtD
Etoricoxib—Nervous system disorder—Epirubicin—thyroid cancer	5.87e-05	0.000588	CcSEcCtD
Etoricoxib—Thrombocytopenia—Epirubicin—thyroid cancer	5.86e-05	0.000587	CcSEcCtD
Etoricoxib—Hypertension—Doxorubicin—thyroid cancer	5.86e-05	0.000587	CcSEcCtD
Etoricoxib—Skin disorder—Epirubicin—thyroid cancer	5.82e-05	0.000582	CcSEcCtD
Etoricoxib—Chest pain—Doxorubicin—thyroid cancer	5.78e-05	0.000578	CcSEcCtD
Etoricoxib—Arthralgia—Doxorubicin—thyroid cancer	5.78e-05	0.000578	CcSEcCtD
Etoricoxib—Anxiety—Doxorubicin—thyroid cancer	5.76e-05	0.000576	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	5.74e-05	0.000574	CcSEcCtD
Etoricoxib—Anorexia—Epirubicin—thyroid cancer	5.71e-05	0.000571	CcSEcCtD
Etoricoxib—Dry mouth—Doxorubicin—thyroid cancer	5.65e-05	0.000566	CcSEcCtD
Etoricoxib—Confusional state—Doxorubicin—thyroid cancer	5.59e-05	0.000559	CcSEcCtD
Etoricoxib—Oedema—Doxorubicin—thyroid cancer	5.54e-05	0.000555	CcSEcCtD
Etoricoxib—Anaphylactic shock—Doxorubicin—thyroid cancer	5.54e-05	0.000555	CcSEcCtD
Etoricoxib—Infection—Doxorubicin—thyroid cancer	5.51e-05	0.000551	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Epirubicin—thyroid cancer	5.46e-05	0.000546	CcSEcCtD
Etoricoxib—Shock—Doxorubicin—thyroid cancer	5.45e-05	0.000546	CcSEcCtD
Etoricoxib—Nervous system disorder—Doxorubicin—thyroid cancer	5.43e-05	0.000544	CcSEcCtD
Etoricoxib—Thrombocytopenia—Doxorubicin—thyroid cancer	5.43e-05	0.000543	CcSEcCtD
Etoricoxib—Insomnia—Epirubicin—thyroid cancer	5.42e-05	0.000542	CcSEcCtD
Etoricoxib—Skin disorder—Doxorubicin—thyroid cancer	5.38e-05	0.000539	CcSEcCtD
Etoricoxib—Dyspnoea—Epirubicin—thyroid cancer	5.34e-05	0.000534	CcSEcCtD
Etoricoxib—Somnolence—Epirubicin—thyroid cancer	5.32e-05	0.000533	CcSEcCtD
Etoricoxib—Anorexia—Doxorubicin—thyroid cancer	5.28e-05	0.000529	CcSEcCtD
Etoricoxib—Dyspepsia—Epirubicin—thyroid cancer	5.27e-05	0.000528	CcSEcCtD
Etoricoxib—Decreased appetite—Epirubicin—thyroid cancer	5.21e-05	0.000521	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Epirubicin—thyroid cancer	5.17e-05	0.000517	CcSEcCtD
Etoricoxib—Fatigue—Epirubicin—thyroid cancer	5.16e-05	0.000517	CcSEcCtD
Etoricoxib—Pain—Epirubicin—thyroid cancer	5.12e-05	0.000512	CcSEcCtD
Etoricoxib—Constipation—Epirubicin—thyroid cancer	5.12e-05	0.000512	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	5.05e-05	0.000505	CcSEcCtD
Etoricoxib—Insomnia—Doxorubicin—thyroid cancer	5.01e-05	0.000502	CcSEcCtD
Etoricoxib—Dyspnoea—Doxorubicin—thyroid cancer	4.94e-05	0.000494	CcSEcCtD
Etoricoxib—Feeling abnormal—Epirubicin—thyroid cancer	4.94e-05	0.000494	CcSEcCtD
Etoricoxib—Somnolence—Doxorubicin—thyroid cancer	4.93e-05	0.000493	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Epirubicin—thyroid cancer	4.9e-05	0.00049	CcSEcCtD
Etoricoxib—Dyspepsia—Doxorubicin—thyroid cancer	4.88e-05	0.000488	CcSEcCtD
Etoricoxib—Decreased appetite—Doxorubicin—thyroid cancer	4.82e-05	0.000482	CcSEcCtD
Etoricoxib—MAPK14—Leptin signaling pathway—AKT1—thyroid cancer	4.81e-05	0.00114	CbGpPWpGaD
Etoricoxib—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	4.79e-05	0.00114	CbGpPWpGaD
Etoricoxib—Gastrointestinal disorder—Doxorubicin—thyroid cancer	4.78e-05	0.000479	CcSEcCtD
Etoricoxib—Fatigue—Doxorubicin—thyroid cancer	4.78e-05	0.000478	CcSEcCtD
Etoricoxib—Urticaria—Epirubicin—thyroid cancer	4.76e-05	0.000476	CcSEcCtD
Etoricoxib—Constipation—Doxorubicin—thyroid cancer	4.74e-05	0.000474	CcSEcCtD
Etoricoxib—Pain—Doxorubicin—thyroid cancer	4.74e-05	0.000474	CcSEcCtD
Etoricoxib—Abdominal pain—Epirubicin—thyroid cancer	4.73e-05	0.000474	CcSEcCtD
Etoricoxib—PTGS2—Disease—TRIM24—thyroid cancer	4.73e-05	0.00112	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—HRAS—thyroid cancer	4.71e-05	0.00112	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—MINPP1—thyroid cancer	4.66e-05	0.0011	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TRIM33—thyroid cancer	4.62e-05	0.0011	CbGpPWpGaD
Etoricoxib—CYP2C19—Biological oxidations—RXRA—thyroid cancer	4.6e-05	0.00109	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—CDK1—thyroid cancer	4.6e-05	0.00109	CbGpPWpGaD
Etoricoxib—Feeling abnormal—Doxorubicin—thyroid cancer	4.57e-05	0.000457	CcSEcCtD
Etoricoxib—MAPK14—Signaling by VEGF—KRAS—thyroid cancer	4.55e-05	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—PTEN—thyroid cancer	4.55e-05	0.00108	CbGpPWpGaD
Etoricoxib—Gastrointestinal pain—Doxorubicin—thyroid cancer	4.53e-05	0.000453	CcSEcCtD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	4.53e-05	0.00108	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—PTEN—thyroid cancer	4.51e-05	0.00107	CbGpPWpGaD
Etoricoxib—MAPK14—Glucocorticoid receptor regulatory network—AKT1—thyroid cancer	4.48e-05	0.00106	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	4.46e-05	0.00106	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CHST14—thyroid cancer	4.44e-05	0.00105	CbGpPWpGaD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—HRAS—thyroid cancer	4.43e-05	0.00105	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Epirubicin—thyroid cancer	4.41e-05	0.000442	CcSEcCtD
Etoricoxib—Urticaria—Doxorubicin—thyroid cancer	4.4e-05	0.000441	CcSEcCtD
Etoricoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—AKT1—thyroid cancer	4.39e-05	0.00104	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—MINPP1—thyroid cancer	4.38e-05	0.00104	CbGpPWpGaD
Etoricoxib—Abdominal pain—Doxorubicin—thyroid cancer	4.38e-05	0.000438	CcSEcCtD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—TP53—thyroid cancer	4.35e-05	0.00103	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—NRAS—thyroid cancer	4.35e-05	0.00103	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—IFNA2—thyroid cancer	4.34e-05	0.00103	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of mRNA stability by proteins that bind AU-rich elements—AKT1—thyroid cancer	4.31e-05	0.00102	CbGpPWpGaD
Etoricoxib—Asthenia—Epirubicin—thyroid cancer	4.3e-05	0.00043	CcSEcCtD
Etoricoxib—MAPK14—Developmental Biology—RXRA—thyroid cancer	4.27e-05	0.00101	CbGpPWpGaD
Etoricoxib—Pruritus—Epirubicin—thyroid cancer	4.24e-05	0.000424	CcSEcCtD
Etoricoxib—CYP2D6—Biological oxidations—RXRA—thyroid cancer	4.23e-05	0.001	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TRIM33—thyroid cancer	4.21e-05	0.001	CbGpPWpGaD
Etoricoxib—CYP2C9—Biological oxidations—RXRA—thyroid cancer	4.2e-05	0.000996	CbGpPWpGaD
Etoricoxib—MAPK14—Senescence and Autophagy in Cancer—HRAS—thyroid cancer	4.16e-05	0.000988	CbGpPWpGaD
Etoricoxib—MAPK14—TCR Signaling Pathway—AKT1—thyroid cancer	4.16e-05	0.000987	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—HRAS—thyroid cancer	4.1e-05	0.000973	CbGpPWpGaD
Etoricoxib—Diarrhoea—Epirubicin—thyroid cancer	4.1e-05	0.00041	CcSEcCtD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.09e-05	0.000972	CbGpPWpGaD
Etoricoxib—MAPK14—Corticotropin-releasing hormone—AKT1—thyroid cancer	4.09e-05	0.00097	CbGpPWpGaD
Etoricoxib—Hypersensitivity—Doxorubicin—thyroid cancer	4.08e-05	0.000409	CcSEcCtD
Etoricoxib—MAPK14—Signaling by NGF—BRAF—thyroid cancer	4.06e-05	0.000964	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—CDK1—thyroid cancer	4.06e-05	0.000963	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	3.98e-05	0.000945	CbGpPWpGaD
Etoricoxib—Asthenia—Doxorubicin—thyroid cancer	3.98e-05	0.000398	CcSEcCtD
Etoricoxib—Dizziness—Epirubicin—thyroid cancer	3.96e-05	0.000396	CcSEcCtD
Etoricoxib—PTGS2—Metabolism—NDUFA13—thyroid cancer	3.96e-05	0.00094	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.95e-05	0.000938	CbGpPWpGaD
Etoricoxib—MAPK14—Oxidative Stress Induced Senescence—TP53—thyroid cancer	3.94e-05	0.000935	CbGpPWpGaD
Etoricoxib—Pruritus—Doxorubicin—thyroid cancer	3.92e-05	0.000392	CcSEcCtD
Etoricoxib—MAPK14—B Cell Receptor Signaling Pathway—AKT1—thyroid cancer	3.92e-05	0.000929	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—NRAS—thyroid cancer	3.91e-05	0.000927	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—IFNA2—thyroid cancer	3.9e-05	0.000926	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—HRAS—thyroid cancer	3.87e-05	0.000919	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—CCND1—thyroid cancer	3.84e-05	0.000912	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	3.81e-05	0.000905	CbGpPWpGaD
Etoricoxib—Vomiting—Epirubicin—thyroid cancer	3.81e-05	0.000381	CcSEcCtD
Etoricoxib—Diarrhoea—Doxorubicin—thyroid cancer	3.79e-05	0.000379	CcSEcCtD
Etoricoxib—Rash—Epirubicin—thyroid cancer	3.78e-05	0.000378	CcSEcCtD
Etoricoxib—Dermatitis—Epirubicin—thyroid cancer	3.77e-05	0.000378	CcSEcCtD
Etoricoxib—MAPK14—Toll-like Receptor Signaling Pathway—AKT1—thyroid cancer	3.76e-05	0.000893	CbGpPWpGaD
Etoricoxib—Headache—Epirubicin—thyroid cancer	3.75e-05	0.000375	CcSEcCtD
Etoricoxib—PTGS2—C-MYB transcription factor network—KRAS—thyroid cancer	3.74e-05	0.000888	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NDUFA13—thyroid cancer	3.73e-05	0.000884	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—CHST14—thyroid cancer	3.72e-05	0.000883	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—PTEN—thyroid cancer	3.72e-05	0.000883	CbGpPWpGaD
Etoricoxib—Dizziness—Doxorubicin—thyroid cancer	3.66e-05	0.000367	CcSEcCtD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—TP53—thyroid cancer	3.62e-05	0.00086	CbGpPWpGaD
Etoricoxib—MAPK14—VEGFA-VEGFR2 Pathway—AKT1—thyroid cancer	3.62e-05	0.000859	CbGpPWpGaD
Etoricoxib—CYP1A2—Biological oxidations—RXRA—thyroid cancer	3.59e-05	0.000851	CbGpPWpGaD
Etoricoxib—Nausea—Epirubicin—thyroid cancer	3.56e-05	0.000356	CcSEcCtD
Etoricoxib—Vomiting—Doxorubicin—thyroid cancer	3.52e-05	0.000353	CcSEcCtD
Etoricoxib—CYP2E1—Metabolism—CHST14—thyroid cancer	3.5e-05	0.000832	CbGpPWpGaD
Etoricoxib—Rash—Doxorubicin—thyroid cancer	3.49e-05	0.00035	CcSEcCtD
Etoricoxib—Dermatitis—Doxorubicin—thyroid cancer	3.49e-05	0.000349	CcSEcCtD
Etoricoxib—MAPK14—Immune System—TPR—thyroid cancer	3.49e-05	0.000828	CbGpPWpGaD
Etoricoxib—Headache—Doxorubicin—thyroid cancer	3.47e-05	0.000347	CcSEcCtD
Etoricoxib—MAPK14—Gene Expression—TPR—thyroid cancer	3.47e-05	0.000823	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—KRAS—thyroid cancer	3.46e-05	0.000822	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—LGALS3—thyroid cancer	3.46e-05	0.000821	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PRKAR1A—thyroid cancer	3.43e-05	0.000814	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	3.43e-05	0.000813	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by VEGF—AKT1—thyroid cancer	3.42e-05	0.000811	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MINPP1—thyroid cancer	3.38e-05	0.000802	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—KRAS—thyroid cancer	3.36e-05	0.000798	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—NRAS—thyroid cancer	3.32e-05	0.000788	CbGpPWpGaD
Etoricoxib—Nausea—Doxorubicin—thyroid cancer	3.29e-05	0.000329	CcSEcCtD
Etoricoxib—MAPK14—Gene Expression—MEN1—thyroid cancer	3.26e-05	0.000774	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NRG1—thyroid cancer	3.26e-05	0.000773	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—HRAS—thyroid cancer	3.23e-05	0.000767	CbGpPWpGaD
Etoricoxib—PTGS2—C-MYB transcription factor network—HRAS—thyroid cancer	3.18e-05	0.000754	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MINPP1—thyroid cancer	3.11e-05	0.000738	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MINPP1—thyroid cancer	3.08e-05	0.000732	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TCF7L1—thyroid cancer	3.08e-05	0.000731	CbGpPWpGaD
Etoricoxib—MAPK14—TGF-beta Signaling Pathway—AKT1—thyroid cancer	3.06e-05	0.000726	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3.03e-05	0.00072	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—HPGD—thyroid cancer	3e-05	0.000712	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—TP53—thyroid cancer	2.99e-05	0.000709	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—HRAS—thyroid cancer	2.97e-05	0.000705	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—HRAS—thyroid cancer	2.94e-05	0.000698	CbGpPWpGaD
Etoricoxib—MAPK14—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	2.94e-05	0.000697	CbGpPWpGaD
Etoricoxib—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	2.91e-05	0.000691	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NDUFA13—thyroid cancer	2.88e-05	0.000682	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—PTEN—thyroid cancer	2.86e-05	0.000679	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—KRAS—thyroid cancer	2.86e-05	0.000678	CbGpPWpGaD
Etoricoxib—MAPK14—BDNF signaling pathway—AKT1—thyroid cancer	2.85e-05	0.000677	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—HPGD—thyroid cancer	2.82e-05	0.00067	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TCF7L1—thyroid cancer	2.81e-05	0.000667	CbGpPWpGaD
Etoricoxib—CYP3A4—Biological oxidations—RXRA—thyroid cancer	2.77e-05	0.000657	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular Senescence—TP53—thyroid cancer	2.75e-05	0.000654	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CHST14—thyroid cancer	2.7e-05	0.000642	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.7e-05	0.00064	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—PPARG—thyroid cancer	2.69e-05	0.000639	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NDUFA13—thyroid cancer	2.64e-05	0.000628	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MINPP1—thyroid cancer	2.63e-05	0.000625	CbGpPWpGaD
Etoricoxib—MAPK14—Insulin Signaling—AKT1—thyroid cancer	2.62e-05	0.000623	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NDUFA13—thyroid cancer	2.62e-05	0.000622	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	2.62e-05	0.000621	CbGpPWpGaD
Etoricoxib—MAPK14—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	2.6e-05	0.000617	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—NRAS—thyroid cancer	2.55e-05	0.000606	CbGpPWpGaD
Etoricoxib—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	2.53e-05	0.000601	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	2.52e-05	0.000599	CbGpPWpGaD
Etoricoxib—MAPK14—MAPK Signaling Pathway—AKT1—thyroid cancer	2.52e-05	0.000599	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CHST14—thyroid cancer	2.49e-05	0.00059	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CHST14—thyroid cancer	2.46e-05	0.000585	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.43e-05	0.000578	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	2.43e-05	0.000576	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—CDK1—thyroid cancer	2.36e-05	0.000561	CbGpPWpGaD
Etoricoxib—MAPK14—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.28e-05	0.00054	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IFNA2—thyroid cancer	2.27e-05	0.00054	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TSHR—thyroid cancer	2.26e-05	0.000535	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NDUFA13—thyroid cancer	2.24e-05	0.000532	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PRKAR1A—thyroid cancer	2.22e-05	0.000527	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—KRAS—thyroid cancer	2.2e-05	0.000521	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—RXRA—thyroid cancer	2.18e-05	0.000518	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HPGD—thyroid cancer	2.18e-05	0.000517	CbGpPWpGaD
Etoricoxib—MAPK14—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	2.14e-05	0.000509	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MEN1—thyroid cancer	2.12e-05	0.000503	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CHST14—thyroid cancer	2.11e-05	0.0005	CbGpPWpGaD
Etoricoxib—MAPK14—Cellular responses to stress—TP53—thyroid cancer	2.08e-05	0.000494	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TPR—thyroid cancer	2.06e-05	0.000488	CbGpPWpGaD
Etoricoxib—MAPK14—Metabolism of mRNA—AKT1—thyroid cancer	2.04e-05	0.000484	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MINPP1—thyroid cancer	2.03e-05	0.000483	CbGpPWpGaD
Etoricoxib—MAPK14—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.03e-05	0.000481	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PRKAR1A—thyroid cancer	2.02e-05	0.00048	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HPGD—thyroid cancer	2e-05	0.000476	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HPGD—thyroid cancer	1.99e-05	0.000472	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.94e-05	0.00046	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MEN1—thyroid cancer	1.93e-05	0.000459	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTCH1—thyroid cancer	1.92e-05	0.000455	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NRG1—thyroid cancer	1.9e-05	0.00045	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—HRAS—thyroid cancer	1.87e-05	0.000443	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.77e-05	0.000419	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SST—thyroid cancer	1.75e-05	0.000416	CbGpPWpGaD
Etoricoxib—MAPK14—Metabolism of RNA—AKT1—thyroid cancer	1.75e-05	0.000415	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NDUFA13—thyroid cancer	1.73e-05	0.00041	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—TPR—thyroid cancer	1.72e-05	0.000409	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.72e-05	0.000409	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HPGD—thyroid cancer	1.7e-05	0.000403	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PRKAR1A—thyroid cancer	1.7e-05	0.000402	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CALCA—thyroid cancer	1.69e-05	0.000401	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling by NGF—AKT1—thyroid cancer	1.65e-05	0.000391	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—NRAS—thyroid cancer	1.65e-05	0.000391	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—PTEN—thyroid cancer	1.63e-05	0.000387	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CHST14—thyroid cancer	1.63e-05	0.000386	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—TPR—thyroid cancer	1.62e-05	0.000385	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—NRAS—thyroid cancer	1.62e-05	0.000384	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.61e-05	0.000382	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PRKAR1A—thyroid cancer	1.6e-05	0.000379	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CALCA—thyroid cancer	1.54e-05	0.000366	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.54e-05	0.000365	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDK1—thyroid cancer	1.53e-05	0.000363	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—NRAS—thyroid cancer	1.46e-05	0.000345	CbGpPWpGaD
Etoricoxib—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.45e-05	0.000345	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—KRAS—thyroid cancer	1.42e-05	0.000337	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDK1—thyroid cancer	1.39e-05	0.000331	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—KRAS—thyroid cancer	1.39e-05	0.00033	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—PPARG—thyroid cancer	1.38e-05	0.000327	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.38e-05	0.000327	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HPGD—thyroid cancer	1.31e-05	0.000311	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—SLC5A5—thyroid cancer	1.29e-05	0.000306	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—KRAS—thyroid cancer	1.25e-05	0.000297	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TPR—thyroid cancer	1.25e-05	0.000297	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—TP53—thyroid cancer	1.24e-05	0.000294	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PRKAR1A—thyroid cancer	1.23e-05	0.000292	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NRG1—thyroid cancer	1.23e-05	0.000291	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—SLC5A5—thyroid cancer	1.21e-05	0.000288	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—HRAS—thyroid cancer	1.21e-05	0.000286	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—HRAS—thyroid cancer	1.18e-05	0.000281	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TPR—thyroid cancer	1.15e-05	0.000273	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TPR—thyroid cancer	1.14e-05	0.000271	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PRKAR1A—thyroid cancer	1.13e-05	0.000269	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	1.12e-05	0.000266	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NRG1—thyroid cancer	1.12e-05	0.000266	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.12e-05	0.000265	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TERT—thyroid cancer	1.1e-05	0.000261	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—RXRA—thyroid cancer	1.08e-05	0.000257	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—HRAS—thyroid cancer	1.07e-05	0.000253	CbGpPWpGaD
Etoricoxib—MAPK14—Developmental Biology—AKT1—thyroid cancer	1.06e-05	0.000253	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.05e-05	0.00025	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HIF1A—thyroid cancer	1.05e-05	0.00025	CbGpPWpGaD
Etoricoxib—MAPK14—Hemostasis—AKT1—thyroid cancer	1.04e-05	0.000248	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—RXRA—thyroid cancer	1.02e-05	0.000242	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.02e-05	0.000241	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TERT—thyroid cancer	1e-05	0.000238	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TPR—thyroid cancer	9.75e-06	0.000231	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HIF1A—thyroid cancer	9.61e-06	0.000228	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	9.59e-06	0.000228	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PTEN—thyroid cancer	9.5e-06	0.000226	CbGpPWpGaD
Etoricoxib—MAPK14—Innate Immune System—AKT1—thyroid cancer	9.4e-06	0.000223	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—SLC5A5—thyroid cancer	9.37e-06	0.000222	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.78e-06	0.000208	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—BRAF—thyroid cancer	8.72e-06	0.000207	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.7e-06	0.000206	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—SLC5A5—thyroid cancer	8.62e-06	0.000204	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—SLC5A5—thyroid cancer	8.54e-06	0.000203	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—NRAS—thyroid cancer	8.48e-06	0.000201	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8e-06	0.00019	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—BRAF—thyroid cancer	7.96e-06	0.000189	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—RXRA—thyroid cancer	7.87e-06	0.000187	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.66e-06	0.000182	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TPR—thyroid cancer	7.53e-06	0.000179	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	7.4e-06	0.000176	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC5A5—thyroid cancer	7.3e-06	0.000173	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KRAS—thyroid cancer	7.3e-06	0.000173	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—RXRA—thyroid cancer	7.24e-06	0.000172	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—RXRA—thyroid cancer	7.18e-06	0.00017	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.98e-06	0.000166	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PPARG—thyroid cancer	6.84e-06	0.000162	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	6.84e-06	0.000162	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PPARG—thyroid cancer	6.44e-06	0.000153	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCND1—thyroid cancer	6.37e-06	0.000151	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HRAS—thyroid cancer	6.2e-06	0.000147	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTEN—thyroid cancer	6.14e-06	0.000146	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—RXRA—thyroid cancer	6.13e-06	0.000146	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	5.97e-06	0.000142	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC5A5—thyroid cancer	5.63e-06	0.000134	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PTEN—thyroid cancer	5.61e-06	0.000133	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NRAS—thyroid cancer	5.48e-06	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AKT1—thyroid cancer	5.48e-06	0.00013	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—AKT1—thyroid cancer	5.45e-06	0.000129	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—thyroid cancer	5.07e-06	0.00012	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NRAS—thyroid cancer	5e-06	0.000119	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PPARG—thyroid cancer	4.97e-06	0.000118	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—RXRA—thyroid cancer	4.73e-06	0.000112	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KRAS—thyroid cancer	4.72e-06	0.000112	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTEN—thyroid cancer	4.69e-06	0.000111	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PPARG—thyroid cancer	4.57e-06	0.000108	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PPARG—thyroid cancer	4.53e-06	0.000108	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTEN—thyroid cancer	4.42e-06	0.000105	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KRAS—thyroid cancer	4.3e-06	0.000102	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—thyroid cancer	4.19e-06	9.95e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HRAS—thyroid cancer	4.01e-06	9.52e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—thyroid cancer	3.91e-06	9.28e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PPARG—thyroid cancer	3.87e-06	9.19e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HRAS—thyroid cancer	3.66e-06	8.68e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—thyroid cancer	3.6e-06	8.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—thyroid cancer	3.56e-06	8.46e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKT1—thyroid cancer	3.54e-06	8.4e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTEN—thyroid cancer	3.41e-06	8.09e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT1—thyroid cancer	3.23e-06	7.67e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTEN—thyroid cancer	3.14e-06	7.44e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTEN—thyroid cancer	3.11e-06	7.38e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—thyroid cancer	3.05e-06	7.23e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PPARG—thyroid cancer	2.99e-06	7.09e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKT1—thyroid cancer	2.71e-06	6.42e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTEN—thyroid cancer	2.66e-06	6.3e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKT1—thyroid cancer	2.55e-06	6.04e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—thyroid cancer	2.35e-06	5.58e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTEN—thyroid cancer	2.05e-06	4.87e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKT1—thyroid cancer	1.96e-06	4.66e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKT1—thyroid cancer	1.81e-06	4.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKT1—thyroid cancer	1.79e-06	4.25e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKT1—thyroid cancer	1.53e-06	3.63e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKT1—thyroid cancer	1.18e-06	2.8e-05	CbGpPWpGaD
